FDA hits Mexican drugmaker Degasa with warning letter Tuesday, May 1, 2018 The FDA issued a warning letter to Mexican finished-pharmaceutical manufacturer Degasa for issues including misbranding, failing to conduct adequate testing and problems with its water system.